Axtria Unveils Transformational Agentic AI Platform to Help Life Sciences Companies Deploy, Scale, and Monetize Innovation
Thursday, May 1, 2025
Axtria InsightsMAx.ai Delivers an Enterprise-Grade Flexible Framework with 30+ Ready-to-Deploy Agents, Apps, and APIs
BERKELEY HEIGHTS, N.J., April 23, 2025 /PRNewswire/ -- Axtria Inc., an AI-first data analytics innovator transforming life sciences, today announced its next generation of Axtria InsightsMAx(TM). Powered by agentic AI, the new Axtria InsightsMAx.ai fundamentally reimagines how life sciences organizations harness artificial intelligence through a flexible enterprise-grade platform that accelerates experimentation, deployment, and ROI.
"Axtria InsightsMAx.ai represents a paradigm shift from incremental AI improvements to true business transformation," said Lokesh Jindal, Head of Products at Axtria. "Axtria InsightsMAx.ai serves as essential infrastructure--the plumbing, if you will--that makes agentic AI implementation practical, scalable, and measurable. While others focus on isolated use cases, we've built the interconnected system that enables life sciences companies to rapidly test, deploy, and scale AI innovation across their entire value chain."
Axtria InsightsMAx.ai solves the critical "last mile" problem in enterprise AI implementation by providing not just the technology, but the entire ecosystem needed for successful adoption. The platform's library of specialized life sciences agents creates an adaptable framework that breaks down silos between data analysis, business intelligence, commercial operations, and clinical development, enabling cross-functional transformation that drives tangible business outcomes.
"What sets our platform apart is its ability to serve as both the experimental sandbox and the production highway for agentic AI," said Navdeep Chadha, Chief Technology Officer at Axtria. "Life sciences companies can start small, proving value in controlled environments, then seamlessly scale successful innovations across their organization without rebuilding infrastructure. This dramatically compresses the time from concept to enterprise-wide deployment from years to months or even weeks."
Enterprise-Grade AI Infrastructure: The Foundation for Pharmaceutical Transformation
Axtria InsightsMAx.ai provides a complete ecosystem for agentic AI implementation through three interconnected offerings:
-- Agents: Over 30 domain-specific autonomous agents designed expressly for
life sciences workflows are ready for immediate deployment. These agents
don't just automate tasks, they transform entire processes by
intelligently orchestrating workflows, predicting outcomes, and
continuously improving performance through domain-specific learning.
-- Apps: Pre-built applications with intuitive interfaces enable business
users across the organization to leverage AI capabilities without
technical expertise. These apps integrate seamlessly with existing
systems, allowing companies to enhance current investments rather than
replace them.
-- APIs: Enterprise-grade APIs with pharmaceutical-specific data models and
compliance controls enable developers to rapidly build custom solutions
while maintaining regulatory compliance. This creates an extensible
platform that evolves with emerging business needs.
The Experimentation-to-Production Pipeline: Accelerating Innovation at Scale
For organizations seeking to build their innovation roadmap, Axtria InsightsMAx.ai provides a comprehensive development environment that transforms how companies move from concept to enterprise deployment:
-- Rapid Experimentation: The no-code interface enables cross-functional
teams to prototype AI solutions in days rather than months, with
built-in guardrails that ensure compliance and data integrity throughout
the process.
-- Model Context Protocol Standards: Model Context Protocol (MCP) to
standardize agent access to external data, tools, and services which
enables seamless integration and empowers agents to act intelligently
across real-world pharma contexts.
-- Agent Orchestration: Moving beyond single-purpose AI, the platform
enables organizations to create complex agent networks that collaborate
across functions, breaking down silos and creating end-to-end process
transformation.
-- Enterprise Deployment Framework: Once validated, solutions can be
deployed across global operations with enterprise-grade security,
governance, and scalability, eliminating the "pilot purgatory" that
plagues many innovation initiatives.
-- Continuous Optimization: Built-in monitoring and feedback loops ensure
AI solutions evolve with changing business needs and regulatory
requirements, maximizing long-term ROI.
Delivering Transformational Business Impact
Axtria InsightsMAx.ai is already revolutionizing operations at six of the top ten global pharmaceutical companies, delivering measurable business outcomes that far exceed traditional AI implementations:
-- 90%+ decision accuracy
-- 75%+ increase in speed to insights
-- 40% reduction in operational costs
-- 10X faster onboarding of new products, markets, and teams
Built on Unmatched Domain Expertise and Technological Innovation
Axtria InsightsMAx.ai leverages 14+ years of pharmaceutical-specific data science expertise and proprietary semantic models that understand the nuanced relationships in life sciences data. The platform is powered by domain-tuned large language models (LLMs) developed in partnership with Genloop, delivering superior performance with enhanced control and transparency.
"The pharmaceutical industry faces unique challenges that generic AI solutions simply cannot address effectively," added Chadha. "Our platform combines deep domain knowledge with cutting-edge AI capabilities, creating a purpose-built system that understands the complex interplay of scientific, commercial, and regulatory factors that drive life sciences business transformation."
About Axtria's Products and Solutions
Axtria is proud to work with 16 of the top 20 life sciences companies, globally. From our roots as a trusted consultant to our status as one of the world's leading providers of cloud-based pharmaceutical management software, Axtria powers digital transformations in life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria InsightsMAx.ai is our agentic platform, featuring more than 30 agents, apps, and APIs, along with a full experimentation environment to find the perfect solution for unique business challenges. Axtria SalesIQ(TM) helps optimize field forces and provider engagements. Axtria CustomerIQ(TM) leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ(TM) turns investment analyses into pinpoint strategies. And Axtria DataMAx(TM) and DataMAx(TM) for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration.
About Axtria
Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We're proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit www.axtria.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/axtria-unveils-transformational-agentic-ai-platform-to-help-life-sciences-companies-deploy-scale-and-monetize-innovation-302435504.html
SOURCE Axtria, Inc.
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
The Roadmap to Securing Your Own Digital Domain is Now Available | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
|
